Alvotech (ALVO) vs ANI Pharmaceuticals, Inc. (ANIP)
Alvotech and ANI Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $2.3B against $1.7B — 1.4× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 15.3×. Alvotech grew revenue faster over the last twelve months: 364.3% against 30.9%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs −101.1%) and the higher return on invested capital (11.3% vs 0.00%). Across the 16 metrics below, ANI Pharmaceuticals, Inc. leads on 14 and Alvotech on 2.
Valuation
Profitability
| Metric | ALVO | ANIP | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 60.40% | 53.94% |
| Operating margin | (42.43%) | 15.37% | 0.00% |
| Net margin | (101.05%) | 11.04% | 0.00% |
| Free cash flow margin | 0.00% | 17.12% | 0.00% |
| Return on equity | 0.00% | 20.88% | (0.40%) |
| Return on assets | 0.00% | 7.61% | (3.32%) |
| Return on invested capital | 0.00% | 11.30% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack